The emerging therapy of tirzepatide peptide represents a significant breakthrough in the management of the condition. Distinct from existing therapies, tirzepatide affects dual pathways – the GLP-1 hormone and GIP – providing greater sugar regulation and possible reduction in weight. Experts are studying its long-term benefits and place in the … Read More